Last reviewed · How we verify

NCT06254573

The Relationship Of Ultrasonographic Measurements With Sarcopenia in Stroke

Completed Last updated 12 February 2024
What this trial tests

trial in Hemiplegia in 48 participants. Completed in 13 April 2023.

Timeline
10 May 2022
Primary endpoint
30 December 2022
13 April 2023

Quick facts

Lead sponsorKayseri City Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment48
Start date10 May 2022
Primary completion30 December 2022
Estimated completion13 April 2023
Sites2 locations across Turkey (Türkiye)

Conditions studied

Sponsor

Kayseri City Hospital

Who can join

Adults 34 to 89, any sex, with Hemiplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

introduction:The aim of this study was to show the relationship of distal femoral cartilage and quadriceps thicknesses with functional status and presence of sarcopenia in ambulatory stroke patients with voluntary movement. Materials and Method: Forty-eight patients who were diagnosed with stroke due to cerebrovascular disease, had started voluntary movement, and had a motor recovery of 3 or above according to Brunnstrom's Staging were included in this cross-sectional study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hemiplegia

Currently open trials in the same condition.

Other Kayseri City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06254573.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing